Pro Share Advisors LLC Amneal Pharmaceuticals, Inc. Transaction History

Pro Share Advisors LLC

$42.5 Billion
Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Pro Share Advisors LLC holds 59,493 shares of AMRX stock, worth $498,551. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,493

Previous 30,069 97.85%

Holding current value

$498,551

Previous $250,000 88.4%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$7.69 - $9.25 $226,270 - $272,172	29,424 Added 97.85%	59,493 $471,000
Q3 2024 Nov 13, 2024	BUY	$6.42 - $8.83 $88,223 - $121,341	13,742 Added 84.17%	30,069 $250,000
Q2 2024 Aug 13, 2024	SELL	$5.36 - $7.11 $29,882 - $39,638	-5,575 Reduced 25.45%	16,327 $103,000
Q1 2024 May 08, 2024	BUY	$5.24 - $6.34 $9,044 - $10,942	1,726 Added 8.55%	21,902 $132,000
Q4 2023 Feb 14, 2024	BUY	$3.36 - $6.21 $14,585 - $26,957	4,341 Added 27.41%	20,176 $122,000
Q3 2023 Nov 13, 2023	SELL	$2.76 - $4.59 $52 - $87	-19 Reduced 0.12%	15,835 $66,000
Q2 2023 Aug 10, 2023	BUY	$1.33 - $3.1 $4,964 - $11,572	3,733 Added 30.8%	15,854 $49,000
Q1 2023 May 11, 2023	SELL	$1.27 - $2.7 $1,437 - $3,056	-1,132 Reduced 8.54%	12,121 $16,000
Q4 2022 Feb 02, 2023	BUY	$1.96 - $2.61 $3,724 - $4,959	1,900 Added 16.74%	13,253 $26,000
Q3 2022 Nov 04, 2022	SELL	$2.02 - $3.62 $436 - $781	-216 Reduced 1.87%	11,353 $23,000
Q2 2022 Aug 01, 2022	SELL	$3.01 - $4.46 $21,482 - $31,831	-7,137 Reduced 38.15%	11,569 $37,000
Q1 2022 May 10, 2022	SELL	$3.9 - $4.89 $11,996 - $15,041	-3,076 Reduced 14.12%	18,706 $78,000
Q4 2021 Feb 08, 2022	BUY	$3.95 - $5.85 $35,573 - $52,685	9,006 Added 70.49%	21,782 $105,000
Q3 2021 Nov 12, 2021	SELL	$4.31 - $5.64 $56,435 - $73,850	-13,094 Reduced 50.61%	12,776 $68,000
Q2 2021 Aug 13, 2021	SELL	$5.12 - $6.82 $3,348 - $4,460	-654 Reduced 2.47%	25,870 $132,000
Q1 2021 May 14, 2021	BUY	$4.74 - $7.38 $21,576 - $33,593	4,552 Added 20.72%	26,524 $179,000
Q4 2020 Feb 09, 2021	BUY	$3.95 - $5.42 $38,773 - $53,202	9,816 Added 80.75%	21,972 $100,000
Q3 2020 Nov 13, 2020	SELL	$3.54 - $5.27 $4,686 - $6,977	-1,324 Reduced 9.82%	12,156 $47,000
Q2 2020 Aug 03, 2020	BUY	$2.87 - $5.46 $38,687 - $73,600	13,480 New	13,480 $64,000
Q1 2020 May 15, 2020	SELL	$2.46 - $5.35 $39,426 - $85,744	-16,027 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$2.65 - $5.56 $14,185 - $29,762	5,353 Added 50.15%	16,027 $77,000
Q3 2019 Nov 12, 2019	SELL	$2.29 - $7.1 $1,099 - $3,408	-480 Reduced 4.3%	10,674 $31,000
Q2 2019 Aug 13, 2019	SELL	$6.44 - $14.29 $9,556 - $21,206	-1,484 Reduced 11.74%	11,154 $80,000
Q1 2019 May 15, 2019	BUY	$11.87 - $14.84 $13,781 - $17,229	1,161 Added 10.12%	12,638 $179,000
Q4 2018 Feb 14, 2019	SELL	$13.09 - $21.49 $23,431 - $38,467	-1,790 Reduced 13.49%	11,477 $155,000
Q3 2018 Nov 14, 2018	BUY	$16.4 - $24.27 $639 - $946	39 Added 0.29%	13,267 $294,000
Q2 2018 Aug 13, 2018	BUY	$13.95 - $20.2 $184,530 - $267,205	13,228 New	13,228 $217,000

Others Institutions Holding AMRX

# of Institutions

205

Shares Held

123M

Call Options Held

362K

Put Options Held

141K

View Full List

About Amneal Pharmaceuticals, Inc.

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.27B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

More about AMRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account

Pro Share Advisors LLC Amneal Pharmaceuticals, Inc. Transaction History